AG
Annie Godara
commericial strategy and intelligence lead
Cromerix
I'm working on
5 months ago
Cromerix develops rapid, onsite microbiological testing using its ApQET™ platform, delivering Gram- and species-specific detection, microbial burden, and real-time growth insight within minutes to hours to enable same-day batch release and faster contamination response.
I'm looking for
6 months ago
We are looking to collaborate with regulated manufacturers to pilot ApQET™ in QC workflows, including bioburden testing, batch release, and antimicrobial effectiveness assessment. Open to feasibility studies to quantify time savings, risk reduction, and operational impact.
About
Cromerix is a biotechnology company developing rapid, onsite microbiological testing for regulated manufacturing. Its ApQET™ platform delivers actionable insight by combining detection, microbial burden, and real-time growth monitoring in a single-step assay. Traditional methods take 2–21 days, delaying release and limiting response. ApQET™ reduces this to minutes to hours, enabling same-day batch release, faster root-cause identification, and earlier risk visibility. Designed for QC environments, it uses a simple add-sample-and-read workflow, requires no complex preparation, and works with standard fluorescence readers, supporting deployment closer to production and more responsive decision-making.
Partnering listings
Learn more
AG
Annie Godara
commericial strategy and intelligence lead
Cromerix
Work experience
Cromerix
commericial strategy and intelligence lead
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Open to opportunities in
Artificial IntelligenceBiochemical EngineeringBiochemistryBiotechnologyComputer ScienceDiagnostics
Last updated May 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.